Skip to content
OpenCapital
Get started

Aehr Test Systems AEHR Prospectus Supplement Amount

Other financials

Income statement

See full
Revenue$10.3M-43.7%
Gross profit$3.4M-53.1%
Operating income-$4.2M-278%
Net income-$3.2M-398%
EPS (diluted)-$0.10-400%

Balance sheet

See full
Cash & equivalents$37.1M+18.2%
Total debt$10.0M+55.7%
Total equity$138.8M+11.7%
Total assets$157.0M+7.9%

Cash flow

See full
Operating cash flow-$5.1M-0.9%
CapEx$1.9M-11.1%
Free cash flow-$7.1M+2.7%

Valuation

See full
Market cap$3.22B+424%

Profitability

See full
Gross margin39.5%-8.0pp
Operating margin14.3%+0.7pp
Net margin44.2%+27.4pp

Returns & leverage

See full
Return on equity32.3%+20.3pp
Debt / equity0.1×0.0×
Current ratio11×+5.3×

Where this comes from

Reported directly by Aehr Test Systems in its filing.

Tagged under the XBRL concept aehr:ProspectusSupplementAmount.

The official record: Aehr Test Systems’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Aehr Test Systems's prospectus supplement amount?
Aehr Test Systems (AEHR) reported prospectus supplement amount of $40M in Q4 2024.